BRIEF published on 09/02/2026 at 09:05, 1 month 11 days ago Aiforia Technologies Oyj: Financial Performance and Outlook Financial Report Recurring Revenue Financial Outlook Hold Rating Aiforia Technologies Oyj
PRESS RELEASE published on 09/02/2026 at 09:00, 1 month 11 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): HOLD NuWays AG research updates recommendation for Aiforia Technologies Oyj with H1'26 review showing costs above expectations. Funding and revenue outlook discussed Funding NuWays AG Revenue Outlook Aiforia Technologies Oyj H1'26 Review
BRIEF published on 07/23/2026 at 09:05, 2 months 21 days ago Aiforia Technologies Downgraded to 'Hold' Following Profit Warning NuWays AG Revenue Decline Profit Warning Aiforia Technologies Stock Downgrade
PRESS RELEASE published on 07/23/2026 at 09:00, 2 months 21 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): HOLD Aiforia Technologies Oyj downgraded to HOLD after issuing H1 profit warning with revenues at €0.75m, order book at €3.5m, and mid-term targets for financial independence by 2027 Revenues HOLD Financial Independence Profit Warning Aiforia Technologies Oyj
BRIEF published on 06/29/2026 at 09:05, 3 months 14 days ago Aiforia Technologies Oyj Strengthens Financial Position with New Share Issue Revenue Growth Financial Strategy Share Issue Aiforia Technologies AI-Powered Pathology
PRESS RELEASE published on 06/29/2026 at 09:00, 3 months 14 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj completes €6.4m share issue, raising sufficient liquidity. Placement de-risks investment case, sets stage for revenue ramp-up and clinical momentum acceleration Liquidity Investment Share Issue Aiforia Technologies Oyj Revenue Ramp-up
BRIEF published on 06/17/2026 at 09:05, 3 months 26 days ago Aiforia Technologies Secures Potential €20M EIB Venture Debt European Investment Bank Non-binding Agreement Aiforia Technologies Venture Debt Funding Outlook
PRESS RELEASE published on 06/17/2026 at 09:00, 3 months 26 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj agrees on a non-binding indicative term sheet with the European Investment Bank (EIB) for a venture debt facility of up to € 20m, de-risking funding outlook and boosting investor confidence Investor Confidence European Investment Bank Aiforia Technologies Oyj Funding Outlook Venture Debt Facility
BRIEF published on 05/11/2026 at 09:05, 5 months 2 days ago NuWays AG Recommends Buy for Aiforia Technologies Oyj NuWays AG Oncology Diagnostics Aiforia Technologies AI Pathology Healthcare M&A
PRESS RELEASE published on 05/11/2026 at 09:00, 5 months 2 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Update on Aiforia Technologies Oyj classification from NuWays AG including strong market catalyst and analysis on AI pathology in the clinical oncology diagnostics field NuWays AG Market Analysis Oncology Diagnostics Aiforia Technologies Oyj AI Pathology
Published on 10/13/2026 at 14:10, 11 minutes ago NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 21 minutes ago Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
Published on 10/13/2026 at 14:00, 21 minutes ago Fermi Signs Credit Support Agreement with AMD and Announces Partnership
Published on 10/13/2026 at 13:30, 51 minutes ago British Columbia Court Declares The Helix Resources Joint Venture on The Gold Basin Property is Set Aside and is Unenforceable
Published on 10/13/2026 at 13:30, 51 minutes ago Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update
Published on 10/13/2026 at 14:05, 16 minutes ago IDC Raises 2029 Forecast for OCP-Recognized Infrastructure Spending by 2.7x to $800 Billion
Published on 10/13/2026 at 14:00, 21 minutes ago Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patient
Published on 10/13/2026 at 13:14, 1 hour 7 minutes ago EQS-Adhoc: ElringKlinger raises 2026 full-year revenue guidance
Published on 10/13/2026 at 09:04, 5 hours 16 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 20 hours 21 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 20 hours 36 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 22 hours 33 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
